Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 34 min ago
Peer-reviewedLicence not statedFuture Medicinal Chemistry

New hybrid molecules with 2,3,4,9-tetrahydro-1H-carbazol-1,3,4-oxadiazole-N-phenylacetamide framework as potent cholinesterase inhibitors

  • Reza Hassanzadeh Dostkoh1
  • Navid Dastyafteh1
  • Aida Iraji2,3
  • Somaye Karimian4
  • Maryam Mohammadi-Khanaposhtani5
  • Sajedeh Safapoor1
  • Milad Noori1
  • Elahe Tahmasebi6
  • Saeedeh Saeedi1
  • Bagher Larijani7
  • Mohammad Mahdavi7
  • Shahrzad Javanshir1
7 affiliations
  1. 1Pharmaceutical and Heterocyclic Compounds Research Laboratory, Department of Chemistry, Iran University of Science and Technology, Tehran, Iran
  2. 2Stem Cells Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  3. 3Research Center for Traditional Medicine and History of Medicine, Department of Persian Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
  4. 4Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  5. 5Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
  6. 6Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  7. 7Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
Read full textDOICite

Related

  1. Rhodanine and 2,4-dioxothiazolidine-based amides: synthesis and evaluation as dual-action cholinesterase inhibitors and antioxidants.
    Enikő Šikorová, Adéla Kyslíková, Markéta Švarcová +3
    RSC medicinal chemistryPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  2. Design and Synthesis of New Thiazole Derivatives for Alzheimer’s Disease Therapy as a Potential Cholinesterase Inhibitor; Toxicity Prediction and Molecular Docking Studies and Biological Evaluation
    Mesut Işık, Gresa Halimi Syla, Abdüllatif Karakaya +7
    Molecules (Basel, Switzerland)Peer-reviewedCC BYFull textPharmacology & toxicologyEurope PMCCrossref
  3. Phytochemical Phenolic Profile, Cholinesterase and α-Glucosidase Inhibitory Activities Rationalized by Molecular Docking, and Antioxidant Capacity of Hibiscus sabdariffa.
    Ashwell Rungano Ndhlala, Emrah Dikici, Sevgi Altın +4
    Molecules (Basel, Switzerland)Peer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  4. Hemp bark extract attenuates scopolamine-induced cognitive dysfunction through multi-target cholinesterase, MAO-B, and antioxidant mechanisms.
    Hee-Young Heo, Jae Kwon Kim, SeonJu Park +3
    Biochemistry and biophysics reportsPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  5. Determination of the Content of Isoquinoline Alkaloids in Selected Plant Extracts and Study of Their Cholinesterase-Inhibiting Activity and Cytotoxicity Against Human Melanoma Cells Using In Vitro and In Silico Methods
    Tomasz Tuzimski, Anna Petruczynik, Mateusz Sugajski +4
    Molecules (Basel, Switzerland)Peer-reviewedCC BYFull textPharmacology & toxicologyEurope PMCCrossref

Cite

BibTeXRIS
BibTeX
@article{dostkoh2026hybrid,
  title = {{New hybrid molecules with 2,3,4,9-tetrahydro-1H-carbazol-1,3,4-oxadiazole-N-phenylacetamide framework as potent cholinesterase inhibitors}},
  author = {Reza Hassanzadeh Dostkoh and Navid Dastyafteh and Aida Iraji and Somaye Karimian and Maryam Mohammadi-Khanaposhtani and Sajedeh Safapoor and Milad Noori and Elahe Tahmasebi and Saeedeh Saeedi and Bagher Larijani and Mohammad Mahdavi and Shahrzad Javanshir},
  journal = {Future Medicinal Chemistry},
  year = {2026},
  month = oct,
  doi = {10.1080/17568919.2026.2748649},
  url = {https://doi.org/10.1080/17568919.2026.2748649},
}
RIS
TY  - JOUR
TI  - New hybrid molecules with 2,3,4,9-tetrahydro-1H-carbazol-1,3,4-oxadiazole-N-phenylacetamide framework as potent cholinesterase inhibitors
AU  - Reza Hassanzadeh Dostkoh
AU  - Navid Dastyafteh
AU  - Aida Iraji
AU  - Somaye Karimian
AU  - Maryam Mohammadi-Khanaposhtani
AU  - Sajedeh Safapoor
AU  - Milad Noori
AU  - Elahe Tahmasebi
AU  - Saeedeh Saeedi
AU  - Bagher Larijani
AU  - Mohammad Mahdavi
AU  - Shahrzad Javanshir
PY  - 2026
DA  - 2026/10/21
JO  - Future Medicinal Chemistry
DO  - 10.1080/17568919.2026.2748649
UR  - https://doi.org/10.1080/17568919.2026.2748649
SN  - 1756-8919
SN  - 1756-8927
ER  -